Tulex Pharmaceuticals Inc.March 24, 2025

FDA 483 - Tulex Pharmaceuticals Inc. - March 24, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Tulex Pharmaceuticals Inc.

Record Details

Tulex Pharmaceuticals Inc. in Cranbury, NJ, a manufacturer of finished drug products, received a Form 483 for significant deficiencies in their quality system. The inspection revealed failures to thoroughly investigate stability failures of finished drug products and inadequate corrective and preventive action procedures. Additionally, the firm lacked scientifically sound laboratory controls and testing procedures for organic impurity analysis.

Company: Tulex Pharmaceuticals Inc.
Inspection Date: March 24, 2025
Product Type: Drugs
Office: New Jersey District Office
People: Suchan Kim
James R. Birkenstamm

Open in Dashboard

ID · a13a486c-928d-431f-847a-5d4f12d53869